11/11
08:00 am
nuwe
Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights
High
Report
Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights
11/5
09:44 am
nuwe
Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds [Yahoo! Finance]
Low
Report
Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds [Yahoo! Finance]
11/5
09:28 am
nuwe
Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds
High
Report
Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds
11/4
08:30 am
nuwe
Nuwellis Receives Increased Reimbursement Rate for Aquadex SmartFlow® Therapy from the Centers for Medicare and Medicaid
High
Report
Nuwellis Receives Increased Reimbursement Rate for Aquadex SmartFlow® Therapy from the Centers for Medicare and Medicaid
11/1
04:15 pm
nuwe
Nuwellis Announces Preliminary Results for Third Quarter of 2024
High
Report
Nuwellis Announces Preliminary Results for Third Quarter of 2024
10/31
08:00 am
nuwe
Nuwellis Welcomes University of Iowa Health Care Stead Family Children’s Hospital as Newest Pediatric Customer
High
Report
Nuwellis Welcomes University of Iowa Health Care Stead Family Children’s Hospital as Newest Pediatric Customer
10/23
04:15 pm
nuwe
Nuwellis, Inc. To Report Third Quarter 2024 Financial Results on November 11, 2024
Medium
Report
Nuwellis, Inc. To Report Third Quarter 2024 Financial Results on November 11, 2024
9/25
04:15 pm
nuwe
Nuwellis to Present at the Third Annual ROTH Healthcare Opportunities Conference
Medium
Report
Nuwellis to Present at the Third Annual ROTH Healthcare Opportunities Conference
8/27
09:00 am
nuwe
New Study Published in Current Problems in Cardiology Highlights Statistically Significant Reduction in Heart Failure Readmissions at 60 days when using the Aquadex Ultrafiltration Therapy
High
Report
New Study Published in Current Problems in Cardiology Highlights Statistically Significant Reduction in Heart Failure Readmissions at 60 days when using the Aquadex Ultrafiltration Therapy
8/23
09:00 am
nuwe
Nuwellis Announces Pricing of $916,000 Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
High
Report
Nuwellis Announces Pricing of $916,000 Registered Direct Offering Priced At-The-Market Under Nasdaq Rules